Category I+D

25 Mar

Dr. Josep Vergés and the OAFI Foundation

Bioibérica is a pharmaceutical company whose industrial plant is located in Palafolls, Barcelona. Dr. Josep Vergés Milano invited me to visit the factory and to give a research seminar on neurodegeneration and pharmacological neuroprotection. It was the late twentieth century and Josep headed the Research and Development Department of Bioibérica, a leading company in the […]

21 Mar

ARTICULANDO EL DEPORTE: La salud de los deportistas en juego. Solo el 65% de los lesionados consigue volver al deporte

CONCLUSIONES DEL V CONGRESO ARTICULANDO EL DEPORTE Barcelona, 21 de marzo de 2025. La artrosis, una enfermedad que tradicionalmente se asocia con el envejecimiento, y que ya la padecen más de 7 millones de personas en España, afecta a casi un tercio de los atletas a lo largo de su carrera, en muchos casos como […]

19 Mar

Arthrosis and Tobacco: AFRONTAR, the smoking cessation process

Smoking is seriously detrimental to health, and there is no doubt about it. It has been shown to be related to various diseases, such as cancer, respiratory, cardiovascular, digestive and urinary system problems, among others. In fact, tobacco kills half of its consumers, as stated by the World Health Organization (OMS). In any case, it […]

27 Feb

SUBMIT YOUR OFFICIAL ABSTRACT IN #ARTICULANDO25

The 5th Articulando el Deporte Congress #ARTICULANDO25, organized by the OAFI Foundation, the Atlético de Madrid Foundation and the Spanish Olympic Committee will take place on March 5 and 6 at the Spanish Olympic Committee Headquarters, Madrid. The Sports Health Congress On March 5 and 6, Madrid will host the 5th Articulating Sport Congress, a […]

5 Feb

Arterial hypertension and rheumatic diseases: relationship or interaction?

Article courtesy of Dr. Mariano de la Figuera, Internal Medicine Specialist. Castelldefels Medical Center Hypertension (HT), defined by a sustained elevation of blood pressure both in the health professional’s office (BP>140/90 mmHg) and outpatient (BP>135/85 mmHg), is the main modifiable risk factor – unlike, for example, age or gender – for vascular diseases such as […]

3 Feb

OAFI and AECOSAR sign agreement with AEEM

AECOSAR and OAFI have signed a collaboration agreement with a key multidisciplinary group in the diagnosis and care of the patient with osteoarticular pathology, often accompanied by other comorbidities, as is the SPANISH ASSOCIATION FOR THE STUDY OF MENOPAUSE (AEEM) , with the objective of establishing a framework of action for the collaboration of the parties […]

28 Jan

Joint pain: What clinical trials and emerging therapies are being developed?

Joint pain affects millions of people worldwide. It is a disorder that weakens and limits people’s ability to function in everyday life. Different conventional treatments and emerging therapies are available to combat it. However, they are not always effective and often generate negative side effects. However, there is hope for those who suffer from these […]

5 Dec

OAFI RADIO: DYSPHAGIA, SARCOPENIA AND NUTRITION

In last Monday’s show of OAFI RADIO discusses how nutrition can help in cases of dysphagia and sarcopenia, presenting testimonials from patients and experts. The importance of modified textures and safe nutritional products to improve quality of life is highlighted. In addition, the need for socialization and the impact of proper diet on bone and […]

15 Nov

GOAPPS : GET INVOLVED! Global Osteoarthritis Patient Perception Survey

OSTEOARTHRITIS AND GOAPPS Worldwide, osteoarthritis affects more than 595 million people, and it is estimated that this figure will double in the next three decades. It is essential to understand patients’ needs and opinions in order to make future care and treatment options more effective. With this goal in mind, the OA Patients Force international working […]

4 Nov

OAFI Congress24 : More than 300 patients and healthcare professionals meet in Barcelona in defense of osteoarticular health

Barcelona, November 4th, 2024 The International Osteoarthritis Patient Foundation (OAFI) held on October 23, 24 and 25 the 8th edition of the International Congress of Osteoarthritis Patients, the OAFI Congress24, dedicated to joint health, with the aim of informing, raising awareness and training on best practices for the prevention, research and treatment of these pathologies, […]

OAFI is the International Osteoarthritis Foundation, the first and only foundation aimed exclusively at people with osteoarthritis worldwide.

CONTACT

The Foundation

Actions